NICOLAU YVES CLAUDE,LEHN JEAN MARIE,KIEDA CALUDINE
申请号：
IN1080/DELNP/2012
公开号：
IN2012DN01080A
申请日:
2012.02.06
申请国别(地区):
IN
年份:
2012
代理人:
摘要：
Inositol trisphosphate (ITPP) causes normalization of tumor vasculature and is a particularly effective cancer therapy when a second chemotherapeutic agent is administered following partial vascularization. ITPP also treats, alone or in combination, multi-drug resistant cancers. ITPP can also be used to reduce the amount of a second chemotherapeutic drug required for anticancer activity. In addition, ITPP enhances immune response and treats hyperproliferative disorders.
